A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/26 (2006.01) A61K 9/00 (2006.01) A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 9/52 (2006.01) A61K 31/135 (2006.01) A61K 31/401 (2006.01) A61K 31/7052 (2006.01) A61K 47/30 (2006.01) A61K 47/38 (2006.01)
Patent
CA 2364845
Drugs are formulated as unit oral dosage forms by incorporating them into polymeric matrices comprised of hydrophilic polymers that swell upon imbibition of water to a size that is large enough to promote retention of the dosage form in the stomach during the fed mode. The oral formulation is designed for gastric retention and controlled delivery of an incorporated drug into the gastric cavity, and thus administered, the drug is released from the matrix into the gastric fluid by solution diffusion. The swollen polymeric matrix, having achieved sufficient size, remains in the gastric cavity for several hours if administered while the patient is in the fed mode, and remains intact long enough for substantially all of the drug to be released before substantial dissolution of the matrix occurs. The swelling matrix lowers the accessibility of the gastric fluid to the drug and thereby reduces the drug release rate. This process, together with diffusion retardation by selection of specific polymers, polymer molecular weights, and other variables, results in a sustained and controlled delivery rate of the drug to the gastric cavity.
Louie-Helm Jenny
Markey Micheline
Shell John W.
Depomed Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Extending the duration of drug release within the stomach... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Extending the duration of drug release within the stomach..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extending the duration of drug release within the stomach... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2018714